ZEN INVESTING
zen investing
NVIDIA Releases Proteina-Complexa AI Model for Drug Discovery
NVIDIA's new generative AI model designs protein binders with nano- and picomolar binding affinities, validated across 133 targets with pharma partners.
zen investing
NVIDIA and MMseqs2 Revolutionize Protein Design with GPU Acceleration
NVIDIA's collaboration with MMseqs2 enhances protein sequence alignment using GPU acceleration, promising significant advancements in AI-driven drug discovery and protein design.
zen investing
NVIDIA Introduces BioNeMo Blueprint to Revolutionize Protein Binder Design
NVIDIA unveils the BioNeMo Blueprint, a new AI-powered approach to accelerate protein binder design in drug discovery, leveraging GPU-accelerated microservices.
zen investing
NVIDIA: EvolutionaryScale Unveils ESM3 Generative AI Model for Protein Design
EvolutionaryScale launches ESM3, an advanced AI model for protein design, leveraging NVIDIA's H100 GPUs to accelerate biological research.